Møller, Søren, Kirsten Grunnet, Steinbjørn Hansen, Henrik Schult, Mats Holmberg, and Morten Sorensen. “A Phase II Trial With Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy”. Acta Oncologica 51, no. 6 (July 1, 2012): 797–804. Accessed May 16, 2026. https://medicaljournalssweden.se/actaoncologica/article/view/31585.